| FEATX | MIPTX | FEATX / MIPTX | |
| Total Expense Ratio | 1.45 | 1.10 | 132% |
| Annual Report Gross Expense Ratio | 1.45 | 1.10 | 132% |
| Fund Existence | 27 years | 16 years | - |
| Gain YTD | 25.284 | 18.781 | 135% |
| Front Load | 4% | N/A | - |
| Min. Initial Investment | 0 | 100000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 822M | 889M | 92% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 39.61 | 30.39 | 130% |
| Returns for 3 years | 111.10 | 38.12 | 291% |
| Returns for 5 years | 22.26 | -20.36 | -109% |
| Returns for 10 years | 165.57 | 16.33 | 1,014% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BUFZ | 27.92 | 0.01 | +0.04% |
| FT Vest Laddered Moderate Bffr ETF | |||
| AVGX | 51.87 | N/A | N/A |
| Defiance Daily Target 2X Long AVGO ETF | |||
| TPOR | 43.49 | -0.42 | -0.95% |
| Direxion Dly Transp Bull 3X Shrs ETF | |||
| IDNA | 32.03 | -0.32 | -0.99% |
| iShares Genomics Immnlgy & Hlthcr ETF | |||
| UXRP | 10.55 | -0.31 | -2.85% |
| ProShares Ultra XRP ETF | |||